First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)
Go back to First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)| TELEFLEX INCORPORATED (NYSE: TFX) | Delayed: 121.67 -5.33 (4.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $127.00 | 52 Week High | $188.79 | |||
| Open | $126.43 | 52 Week Low | $125.28 | |||
| Day High | $126.43 | P/E | 35.16 | |||
| Day Low | $120.86 | EPS | $3.46 | |||
| Volume | 722,851 | |||||
